26 April 2017
Washington DC
Reporter: Barney Dixon

Patent dance question to be heard today


The US Supreme Court will today (26 April) hear oral arguments in the highly anticipated Amgen v Sandoz litigation on the patent dance procedure.

A decision in favour of Sandoz could lead to a new definition of the patent dance procedures contained in the Biologics Price Competition and Innovation Act (BPCIA).

Amgen asked the Supreme Court whether biosimilar applicants must adhere to the BPCIA’s two-stage process that requires applicants to file an Abbreviated Biologics License Application along with providing the patent owner with information about the applicant’s manufacturing process, otherwise known as the ‘patent dance’.

Applicants then have 180 days to provide the patent owner with notice of Food and Drug Administration (FDA) approval.

Brendan O’Malley, partner at Fitzpatrick, Cella, Harper & Scinto, commented: “Reference product sponsors believe a reversal on this question would lead to chaos, in part because they would have no way to predict when a launch might be imminent, making it difficult to obtain a preliminary injunction before the biosimilars enter the market.”

The Supreme Court also faces a separate question from Sandoz, which asks whether the notice of commercial marketing can be effective in general.

O’Malley said that an affirmation on this question could be a reference sponsor’s sole mechanism for patent enforcement if the biosimilar applicant declines to engage in the patent dance.

“A reversal on this question could help to restore reference product sponsors’ expectation that an early and orderly pathway would exist for enforcing their patent rights.”

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Universities should be more flexible
18 August 2017 | London | Reporter: Barney Dixon
Perceived barriers could potentially be torn down by the Aarhus University’s proposed ‘patent free’ research zone, but academia should not be wedded to a single solution, according to Sean Jauss, partner at Mewburn Ellis
Ericsson sues Wiko over standard-essential patents
17 August 2017 | Stockholm | Reporter: Barney Dixon
Ericsson has sued smartphone maker Wiko for infringement of standard-essential patents for 2G, 3G and 4G technology
Ropes & Gray hires leading PTAB litigator
16 August 2017 | Washington DC | Reporter: Barney Dixon
Ropes & Gray has recruited leading US Patent Trial and Appeal Board litigator Scott McKeown
Trump fires forward in China IP investigation
15 August 2017 | Washington DC | Reporter: Barney Dixon
US President Donald Trump has signed a memorandum asking the US Trade Representative to examine whether China should be investigated for alleged intellectual property malpractice
Nintendo Switch ‘infringes’ Gamevice patent
14 August 2017 | California | Reporter: Barney Dixon
Handheld game controller company Gamevice claimed that the Nintendo Switch infringes its 2015 patent for a slip-on game controller used with a smartphone or tablet
BPO takes radical approach to patent backlog
14 August 2017 | Brasília | Reporter: Barney Dixon
The Brazilian Patent Office has published a proposal that intends to eliminate patentability analysis
Sanofi sues Merck for patent infringement
11 August 2017 | New Jersey | Reporter: Barney Dixon
Sanofi has filed a lawsuit against Merck Sharp & Dohme Corp, alleging infringement of two patents for a diabetes drug